Channel BannerChannel Banner
SUZ9qfP4IMoSUZ9qfP4IMo

Biotechnology Weekly Update - September 28, 2023

1,263
Socialcounts.Org
Enter Fullscreen (f)
2
likes
0
comments
daily view 0
monthly view 0

Share

Live Analytics

Comments 0

Biotechnology Weekly Update - September 28, 2023 Analytics Table

Income Estimates for Biotechnology Weekly Update - September 28, 2023

Based on this YouTube video's total view count of 1.26K views and industry-standard rates, the estimated total earning is $1 - $3 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

About Biotechnology Weekly Update - September 28, 2023

Explore Biotechnology Weekly Update - September 28, 2023 with 1,263 views, 2 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.

🔷Jardiance Gets FDA Nod For Yet Another Indication The FDA has approved a label expansion for Boehringer/Lilly’s Jardiance for the treatment of adults with chronic kidney disease. https://www.rttnews.com/3392170/eli-lilly-fda-approves-jardiance-in-treatment-of-chronic-kidney-disease.aspx 🔷Travere Is Down, But Not Out Travere’s confirmatory data from a phase III study of Filspari in IgA nephropathy narrowly missed the endpoint, sending the stock to a new low. https://www.rttnews.com/3391961/travere-therapeutics-stock-tanks-40-on-late-stage-trial-data-of-kidney-disease-treatment.aspx 🔷Abundant Caution Spurs Action Scynexis is recalling antifungal Brexafemme from the market and suspending clinical trials temporarily due to potential manufacturing cross-contamination concerns. https://www.rttnews.com/3392639/scynexis-recalls-gsk-licensed-ibrexafungerp-tablets-halts-trials-on-contamination-concerns.aspx 🔷Morphic Stock Takes A Hit Morphic shares have been on a downward spiral since the release of data from a phase IIa trial of its inflammatory bowel disease drug MORF-057. https://www.rttnews.com/3392488/morphic-holding-stock-down-14.aspx 🔷Soleno Satisfies Investor Appetite Soleno’s stock surged 500%, thanks to DCCR, a pill to curb excessive appetite, producing statistically significant results in a withdrawal phase of a study. https://www.rttnews.com/3392735/soleno-says-study-c602-met-primary-endpoint-stock-surges-in-premarket.aspx Subscribe to RTT Biotech Investor to get timely updates on Biotech & Pharma industry, and access all the timely news, time-sensitive information, and alerts that can enable you to make sound investment decisions. https://bit.ly/3G5cWiS Follow us on Instagram - https://www.instagram.com/rttnews Twitter- https://twitter.com/rttnews Facebook- https://www.facebook.com/RTTTopStories YouTube - https://www.youtube.com/rttnews #biotech #biotechnology #rttnews #FDA #weeklyupdates #weeklynews #fdaapproved #fdaapproval #boehringeringelheim #kidneydisease #morphic #soleno

About YouTube Real-Time View Count

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.

Embed Widget

Parameters:

  • fullscreen=true - Fullscreen counter
  • graph=true - Live graph chart
  • counter=0/1/2 - Select counter (0=likes, 1=views, 2=comments)
URL

Click to copy the embed URL to your clipboard